The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

ProMetic Life Sciences Inc

TSX: PLI
Delayed quote

$1.95

Today's change0.00 0.00%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

ProMetic Life Sciences Inc

TSX: PLI
Delayed quote

$1.95

Today's change0.00 0.00%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

ProMetic Life Sciences Inc closed at $1.95.

Over the last five days, shares have gained 10.80%, but are currently unchanged over the last year to date. Shares have outperformed the S&P TSX by 42.64% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.08
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-261.16%

Although this company's net profit margin is negative, it is above the industry average and implies that ProMetic Life Sciences Inc is operating more effectively than other companies in the industry.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Biotechnology
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue32112
Total other revenue--------
Total revenue32112
Gross profit2181
Total cost of revenue1121
Total operating expense19201212
Selling / general / administrative4353
Research & development1110128
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)46-70
Other operating expenses, total--------
Operating income-16-18-1-9
Interest income (expense), net non-operating-----1--
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-215-21
Income after tax-14-208-21
Income tax, total-1-1-40
Net income-12-199-19
Total adjustments to net income--------
Net income before extra. items-12-199-19
Minority interest1211
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-12-199-19
Inc. avail. to common incl. extra. items-12-199-19
Diluted net income-12-199-19
Dilution adjustment----00
Diluted weighted average shares569552727531
Diluted EPS excluding extraordinary itemsvalue per share-0.02-0.030.01-0.04
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.02-0.030.01-0.04